|
HS Code |
123774 |
| Product Name | Ethiodized Oil |
| Chemical Name | Ethyl ester of iodinated fatty acids of poppyseed oil |
| Appearance | Clear to pale yellow oily liquid |
| Iodine Content | 480 mg/mL |
| Density | 1.28 g/mL at 20°C |
| Solubility | Insoluble in water, soluble in organic solvents |
| Storage Temperature | Store below 25°C (77°F) |
| Viscosity | 35-40 mPa·s at 20°C |
| Route Of Administration | Injection (intra-arterial, intrathecal, or intratumoral) |
| Primary Use | Contrast agent for radiography, especially lymphography |
As an accredited Ethiodized Oil factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ethiodized Oil is packaged in a 10 mL amber glass vial, with a tamper-evident seal and labeled for sterile use. |
| Shipping | Ethiodized Oil should be shipped in tightly sealed containers, protected from light and stored at controlled room temperature. It is considered non-hazardous for air, land, and sea transport. Ensure labeling complies with regulations, and keep containers upright to prevent leakage. Handle with care to avoid spills and contamination. |
| Storage | Ethiodized oil should be stored at controlled room temperature, typically between 15°C and 30°C (59°F and 86°F). Keep the container tightly closed and protect it from light and moisture. Store it in a secure location away from incompatible substances and out of reach of unauthorized personnel, adhering to standard chemical storage regulations and manufacturer recommendations. |
|
Viscosity grade: Ethiodized Oil viscosity grade 480 cSt is used in transarterial chemoembolization, where it ensures optimal embolic stability and controlled drug delivery. Iodine content: Ethiodized Oil iodine content 480 mg/mL is used in lymphangiography, where it provides high radiographic contrast for enhanced lymphatic vessel visualization. Purity: Ethiodized Oil purity ≥99% is used in interventional radiology procedures, where it minimizes risk of impurities and ensures patient safety. Stability temperature: Ethiodized Oil stability up to 40°C is used in contrast agent preparation, where it maintains chemical integrity during storage and handling. Particle size: Ethiodized Oil particle size <10 μm is used in targeted drug delivery applications, where it facilitates smooth passage through microvasculature. Density: Ethiodized Oil density 1.28 g/cm³ is used in selective arterioportography, where it enables accurate vessel opacification and anatomical delineation. |
Competitive Ethiodized Oil prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Ethiodized oil rarely sparks conversation outside specialized medical circles. Step into any interventional radiology suite or certain oncology clinics, though, and it's another story. This iodinated contrast agent, often recognized by its highly viscous, amber-colored appearance, holds a reputation built over decades. Speaking from years spent around clinical imaging, when precision matters—both in diagnosing and in delivering treatment—this compound finds its way onto the scene.
Most of us will never think about the nuts and bolts of an imaging contrast other than its ability to "show things up on a scan." For patients and healthcare practitioners alike, ethioidized oil goes further than the everyday contrast medium. The oil’s notable viscosity slows its movement through blood vessels, making it useful not just for imaging, but for actually carrying therapeutic agents right to the site of need. It sticks around long enough to be seen, mapped, and utilized, which can make or break a physician’s ability to target disease with confidence.
Modern medicine thrives on accuracy. Every edge counts, especially when cancer treatment or vascular mapping enter the discussion. Ethiodized oil gives doctors and patients reassurance by illuminating certain tissues and structures that other contrast agents zip right past. In my own experience, its use comes up most often in lymphangiography, a procedure to visualize lymphatic vessels—a network other agents tend to underplay on scans. Here, the oil’s thick consistency means it travels slowly, allowing for greater detail in imaging, which proves critical for things like detecting lymphatic leaks or mapping prior to surgery.
Doctors lean on ethioidized oil in more than just imaging. Through techniques like transarterial chemoembolization (TACE), this agent does double duty. The oil not only marks the tumor for imaging, but also helps trap chemotherapy agents within the targeted area. This can directly boost treatment outcomes for patients facing serious liver cancers, such as hepatocellular carcinoma. Given the stakes, no one wants to cut corners. The fact that this oil blends seamlessly with certain drugs, stays localized, and stays visible makes for a unique and useful pairing.
Typical bottles come in a range of concentrations meant to give radiologists control over dose and visualization. Historically, the blend of ethiodized oil relies on iodine’s radiodensity, a quality responsible for the glowing outlines you see on X-ray films and CT scans. Compared to low-viscosity water-soluble agents, the oil behaves more like honey than water. You notice this when prepping syringes or monitoring the spread under live fluoroscopy.
What stands out is its purity—each lot undergoes tight manufacturing scrutiny to minimize contamination, stray particles, or instability that could cloud diagnostic results. This chemical stability matters, especially since the oil can reside within vessels or cavities for extended periods. From the end-user perspective, confidence starts in the supply chain and extends to every scan or procedure performed.
Safety always sits close to the hearts of those who administer contrast. Ethiodized oil, though well tolerated by most, calls for caution in patients with history of hypersensitivity to iodine components or severe allergies. In my years of clinical observation, side effects remain rare but present—pain, inflammation, or mild fever occur if protocols slip or doses run too high. John, a long-time radiologic technologist I once worked with, used to say, “Treat it with respect like you would any medicine—never rush, never guess the history, always double check.” That lesson sticks.
Contrast media come in multiple flavors, each chosen for specific tasks. Water-soluble agents, which dominate everything from routine angiograms to enhanced CTs, move fast through the body and clear out quickly. These solutions work wonders for detecting blood vessel blockages or highlighting rapidly perfused tissues.
Ethiodized oil stands in contrast—literally and figuratively. It travels much slower through the vascular and lymphatic systems, leaving longer-lasting, sharper tracks on imaging. This trait often makes it a first pick for procedures that need longer visualization time, such as lymphangiography, certain hysterosalpingography cases, and the aforementioned TACE. Even outside the major hospitals, seasoned radiologists rely on oil’s slow progress and sticky nature. It makes a difference in pinpointing leaks or abnormal pathways that a fast-clearing agent might miss.
There's a practical difference in handling as well. Loading syringes with the oil compared to water-based contrasts never feels the same. You notice the resistance and see the small air bubbles behave differently. In shared procedure rooms, those subtle signs let medical staff know which medium sits in the injector, reducing error before a scan even starts.
One fact often overlooked: choice of contrast agent can influence both the clarity of the diagnosis and the accuracy of treatment itself. In conditions where a small leak, an intricate lymphatic channel, or microembolization could go unseen, the consequences escalate. I recall a case from a teaching hospital where a patient’s persistent leakage following surgery stubbornly resisted traditional detection. Only after lymphangiography with ethioidized oil did the imaging reveal a slender, hidden vessel responsible for ongoing pain and infection. The surgeon’s relief was palpable—the patient’s ordeal finally had an answer.
There’s a trickle-down benefit. Catching these elusive details with the right tool the first time potentially saves on further imaging, reduces unnecessary interventions, and lessens patient anxiety. From a systems perspective, this translates to tangible cost savings and better outcomes—a small product making a big difference when used for the right reasons.
Some worry about leftover oil hanging around the body, particularly after therapeutic uses, but careful dosing and improved flushing protocols have reduced long-term risks. A responsible radiology team monitors the trade-off between improved visualization and the rare, but possible, complications like granulomatous reactions or embolization of non-target tissues. Regular audits and consensus guidelines reflect this balanced approach.
The landscape of contrast agents evolves with technology and research, but certain tools have staying power for good reason. Newer agents sometimes promise greater clarity or reduced side effects, yet ethioidized oil remains an option that clinicians trust in defined settings. Its use in TACE continues to have support in the literature, particularly for intermediate-stage liver tumors. The sticky property anchors both the medicine and the radiographic outline in place—an asset not easily replicated by low-viscosity alternatives.
In developing healthcare settings, where technology upgrades lag behind aspirations, this oil picks up where pricier, harder-to-source solutions leave off. Stories circulate of rural clinics leveraging long shelf-life and manageable storage of ethioidized oil to keep critical services running despite interruptions or supply shortages. Safety profiles established over decades give new generations of doctors the confidence to follow proven protocols.
No discussion about a medical agent earns credibility without honestly addressing risks. With ethioidized oil, potential allergic reactions, though rare, draw care and attention. The radiology community responds by fostering a strong culture of history-taking and preparedness. Having resuscitation equipment and trained personnel on hand acts as an essential backdrop for all contrast procedures, and team drills make sure everyone stays sharp.
The viscosity that makes the oil valuable in one setting can pose a hazard in another. Injecting the oil into small vessels or at too high a pressure risks blockage, which underscores the need for appropriately-sized catheters and careful injection. Education remains a frontline defense. Trained staff know to draw the agent slowly, warm it to reduce viscosity before use, and never force an injection just to meet a schedule.
Ethiodized oil’s iodine content brings another consideration for thyroid function. Any patient with a history of thyroid disease or recent iodine-based imaging gets extra attention, since excess iodine exposure can disrupt thyroid hormone production. Most of the time, the risks stay theoretical, but stories float around of patients who developed temporary thyroiditis after multiple contrast-based procedures. For frequent users—think oncology patients or those undergoing multiple embolizations—monitoring remains prudent.
Walk into any radiology suite with a high volume of interventional cases, and the support staff usually have a few hard-won tips. For context, I remember a senior nurse who kept track of every contrast agent she ever handled. Ethiodized oil, she would point out, earned a spot in the fridge door for two reasons: it kept the viscosity manageable, and everyone knew to label it clearly to avoid mix-ups. Her rule—always double-check the label and expected appearance—ended more than one potential mishap.
For young trainees, learning to handle the oil safely is almost a rite of passage. The thickness fools a few into thinking something’s wrong with their needle or they missed a step in preparation. On the job, the lesson quickly becomes clear: patience and attention prevent discomfort for the patient and produce the cleanest images. Some of the best proceduralists I’ve known could predict exactly how far the oil would travel and how much to use to avoid both waste and risk.
Patient safety connects directly with training, so continuous education carries as much weight as product innovation. Some hospitals set up simulation labs. These offer hands-on practice under supervision so new users gain confidence before handling real patients. Audit programs, both internal and shared across networks, matter for keeping standards consistent.
On a broader level, investing in labeling and packaging improvements could reduce human error. Modern medicine leans heavily on visual cues, so color-coding or tactile bottle features could pay dividends in busy procedure rooms. In regions with language barriers, universal symbols or pictograms could prevent potentially harmful mix-ups between contrast agents.
Hospitals can also review protocols for post-procedural monitoring. By instituting a checklist approach—verifying patient history, monitoring for reactions, and documenting dose used—teams can catch problems early. This doesn’t just protect the patient; it creates a feedback loop to inform future practice and product development.
In some parts of the world, ethioidized oil bridges the gap between technological limitations and patient need. Its stability at room temperature, longer shelf life, and ease of storage matter where refrigerated supply chains or consistent electricity falter. The World Health Organization includes it in resources for essential medical supplies precisely for this reason—it gets the job done with minimal infrastructure burden.
Clinicians in resource-limited hospitals often need to improvise with what's on hand, and ethioidized oil's long-standing safety record makes it a solid choice where cost and reliability play the largest roles. Reports from field hospitals and disaster zones highlight how the right choice of contrast agent, matched to local capability, can ensure continuity in screening for cancer, infection, or traumatic injury. While newer, flashier products sometimes grab FDA or European regulatory headlines, there's still a global community leaning on oils like this to fill the care gaps.
Ethiodized oil’s resilience goes beyond medicine—it reflects an ethos of adapting established science to serve real people. In teaching sessions, young doctors sometimes ask why older products remain in use. Seasoned clinicians point to the evidence and the outcomes, not to trends. Where safe, cost-effective, and impactful solutions are needed, older methods stay relevant because they work.
Research continues to scrutinize every detail of contrast agents, including ethioidized oil. Modern studies explore optimizing doses, improving emulsification with therapeutic agents, and tightening safety margins for special populations—children, elderly patients, or those with underlying kidney issues.
Clinical trials and real-world case reports both guide policy and practice. They help refine recommendations, address rare adverse effects, and push for improvements in manufacturing quality. For doctors weighing the choice of contrast, the best evidence is always the one that matches patient need, risk factors, and the procedure at hand.
A new trend is the drive toward personalized contrast use—tailoring the product and dose to the patient’s body type, disease profile, and prior history. Some leading centers maintain registries to track outcomes and share best practices, feeding a collaborative loop between institutions and industry. Over time, this approach promises to tighten guidelines and improve both patient safety and diagnostic yield.
In every setting—advanced hospital or rural clinic—the real value of ethioidized oil comes down to people. Doctors, nurses, and technologists use it not because it’s old-fashioned or hard to replace, but because experience and evidence both support its role in specific, high-stakes scenarios. As technology marches on, the risk grows of losing touch with tools that proved trustworthy over time.
Ethiodized oil illustrates the balance modern medicine seeks: old and new, caution and innovation, established protocols and flexible solutions. Every bottle handled, dose measured, or scan reviewed echoes lessons learned from cases before. Those lessons ensure that, amid rapid innovation, patients get what they really need—safe, thoughtful, and effective care grounded in both expertise and compassion.
This perspective shapes the future: respectful use, ongoing education, and data-driven improvement. No single product solves every challenge, but those that stand the test of time almost always owe their success to the practitioners who understand and respect their place in the wider clinical picture.